ISPO

immunotherapy I

Adjuvant interferon alpha treatment of non-metastatic renal cell carcinoma (RCC)-role of selection factors

RF Basting MD, D Händel MD, D Schmidt

Antibody-guided MHC-peptide tetramers on streptavidin can target tumor cells for specific lysis by T lymphocytes

B Robert PhD , P Guillaume PhD , I Luescher PhD , P Romero PhD , J Mach MD

Tumor progression and survival in patients with T1G3 bladder tumors treated with low-dose Pasteur bacille Calmette-Guérin

R Hurle MD , A Manzetti MD , E Micheli MD

Cytokine-Depot Tumor Vaccines: The importance of vaccine composition, dosage, vaccination site and vaccination course

FW Falkenberg PhD, OC Krup PhD, M Peters MSc, R Schröder MSc

Immunogene therapy of human melanoma with il-6 and sil-6r modified tumor cells – clinical and immunological results of a phase ii study

S Nawrocki MD , A Mackiewicz MD PhD , S Rose-John PhD

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

J Dannull PhD, M Groettrup MD

Effect of low-dose subcutaneous (sc) interleukin-2 (IL-2) on disease-free survival (DFS) and overall survival (OS) in patients with B-lymphoid neoplasms in complete remission with high risk of relapse

E González-Barca PhD, E Domingo-Domenech MD, A Fernández-Sevilla PhD, J Petit MD, A Grañena PhD

Involvement of cd44 in cancer and inflammation: mechanism of action and practical implications

SB Wallach , S Nedvetzki , V Grabovsky , J Moll , P Herrlich , I Golan , R Alon , D Naor

Oral isotretinoin therapy for cutaneous sarcoidosis

S Georgiou MD, A Monastirli MD, E Pasmatzi MD, D Tsambaos MD

Clonal expansion of T cells in TIL and autologous PBL stimulated with ovarian cancer cell

K Hayashi MD, K Yonamine PhD, T Iida MD

Cytokine-depot tumor vaccines: Basic principles

FW Falkenberg PhD, OC Krup PhD, M Peters MSc, C Desel MSc, U Falkenberg PhD, R Schröder MSc, I Kroll MSc, G Böse MSc, A Brockmann MSc, A Schulte MSc, B Schoengen MSc, K Zinkant MSc

Cytokine-Depot Tumor Vaccines: The nature of the local cellular processes at the inoculation site

M Peters MSc, J Thiry MSc, S Plöttner MSc, R Schröder MSc, A Schulte MSc, OC Krup PhD, FW Falkenberg PhD

Pancreatic cell carcinoma-derived Vascular Endothelial Factor and Interleukin-10 differentially affect dendritic cells development

C Smirne MD, B Nuschak BS, C Rivetti MD, I Ferrero BS, R Segir BS, A Carbone BS, D Tibaudi MD, F Suman MD, G Emanuelli MD, G Bellone PhD

Interleukin-1 beta (IL-1β) reduces proliferation in the absence of differentiation in multipotent hemopoietic cells

OE Santiago, MG Ramos, MI Martinez, GB Manrique, IR Zambrano-Ramirez, SB Weiss

Inulin synergistically stimulates interferon-gamma-induced nitric oxide synthesis in RAW 2647 macrophages

HM Kim PhD , HN Koo MS , YM Lee PhD , JJ Kim PhD , CH Kim PhD , NH An PhD

Human monoclonal antibody SK-1 immunotargeting therapy for recurrent colorectal cancers

K Koda MD PhD, J Yasutomi MD PhD, N Takiguchi MD PhD, K Oda MD PhD, N Nakajima MD PhD

Bradykinin and bradykinin receptors: Importance for the activation of granulocytes and monocytes/macrophages

S Boeckmann PhD, I Paegelow MD

Patients with squamous cell carcinoma of the head and neck produce a different spectrum of antinuclear antibodies than patients with lung squamous cell carcinoma

F Fernandez-Madrid MD PhD , RL Karvonen PhD , J Ensley MD , M Kraut MD , JL Granda MD PhD , J Tomkiel PhD

Innate and adaptive immunity to tumors: IL-12 is required for optimal responses

P Grufman, K Karre

Challenges and potentials in tumor immunotherapy targeted at the shared tumor antigens

P Zheng MD PhD , XF Bai MD PhD , J Bender MD , Y Liu PhD

Characterization of tumor antigens involved in the activation of gamma-delta T lymphocytes

E Champagne MD, T Al Saati MD PhD, M Guiraud BS

Prophylactic and therapeutic vaccination using a fully synthetic immunogen displaying the saccharidic Tn antigen

R Lo-Man PhD, S Vichier-Guerre PhD , S Bay PhD , E Deriaud, C Leclerc PhD

GM-CSF delivery enhances the antigen specific T-cell response to a novel peptide-based cancer vaccine

CL Nguyen MD, JT Bui BS, M Demcheva PhD, JN Vournakis PhD, DJ Cole MD, A Seth PhD, WE Gillanders MD

Critical role of IL-15/IL-15R system for functions of antigen presenting cells

T Ohteki PhD, S Koyasu PhD

Transduction of CD34+ cells with lentiviral constructs enables the production large numbers of functional transgene-expressing dendritic cells

V Kindler PhD , P Salmon PhD , JF Arrighi PhD , V Piguet MD PhD , B Chapuis MD , D Trono MD , RH Zubler MD

Daily alternating administration of human lymphoblastoid interferon-alpha (HLBI) and recombinant interferon-gamma 1a (IFN-gamma) in patients (pts) with metastatic renal cell carcinoma (MRCC)

A Fujii MD , H Eto MD , Y Ono MD , S Park MD , A Gotoh MD , I Hara MD , S Kamidono MD

Polymorphism of NRAMP-1 gene in patients with superficial bladder cancer treated with BCG immunotherapy

PC Bergami-Santos MSc , FP Fonseca MD , AA Camargo PhD , JAM Barbuto MD PhD

Rituximab administration in patients with lymphoproliferative disorders

KL Bourantas, G Vartholomatos, E Tzouvara, H Kapsali, L Christou, S Tsiara

A new approach to cancer immunotherapy – IFNANK (interferon-alpha activated natural killer lymphocytes) therapy –

S Tomita MD, T Kishida MD PhD, M Tanigawa MD, K Uno PhD, A KishiI PhM, S Fujita MD PhD

Identification of naturally-processed HLA presented epstein-barr virus peptides recognized by CD4+ and CD8+ T lymphocytes from human blood

W Herr MD , E Ranieri PhD , A Gambotto MD , LS Kierstead PhD , AA Amoscato PhD , L Gesualdo MD , WJS Storkus PhD

Recruitment of dendritic cells and enhanced antigen specific immunoreactivity in cancer patients treated with granulocyte-monocyte colony stimulating factor and interleukin 2: results from a phase I-II clinical trial

P Correale , G Campoccia , L Micheli , G Cusi , S Sestini , R Petrioli , D Pozzessere , S Marsili , G Fanetti , G Giorgi , G Francini

In vitro generation of parathyroid hormone related protein (PTH-rP) specific CTL lines

G Francini , G Campoccia , D Pozzessere , M Sabatino , L Lozzi , G Fanetti , P Correale

Combinatons of bispecific antibodies and immunostimulatory cytokines for the treatment of renal cancer

D Elsässer MD , H Stadick , KM Schrott MD , M Gramatzki MD , T Valerius MD